Literature DB >> 1606170

Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma.

E D Bekaert1, P Alaupovic, C Knight-Gibson, R A Norum, M J Laux, M Ayrault-Jarrier.   

Abstract

High density lipoproteins (HDL) consist of a mixture of chemically and functionally distinct families of particles defined by their characteristic apolipoprotein (Apo) composition. The two major lipoprotein families are lipoprotein A-I (LP-A-I) and lipoprotein A-I:A-II (LP-A-I:A-II). This study describes the isolation of a third minor HDL family of particles referred to as lipoprotein A-II (LP-A-II) because it lacks ApoA-I and contains ApoA-II as its main or sole apolipoprotein constituent. Because ApoA-II is an integral protein constituent of three distinct lipoprotein families (LP-A-I:A-II, LP-A-II: B:C:D:E and LP-A-II), LP-A-II particles were isolated from whole plasma by sequential immunoaffinity chromatography on immunosorbers with antisera to ApoA-II, ApoB and ApoA-I, respectively. In normolipidemic subjects, the concentration of LP-A-II particles, based on ApoA-II content, is 4-18 mg/dl accounting for 5-20% of the total ApoA-II not associated with ApoB-containing lipoproteins. The lipid composition of LP-A-II particles is characterized by low percentage of triglycerides and cholesterol esters and a high percentage of phospholipids in comparison with lipid composition of LP-A-I and LP-A-II: A-II. The major part of LP-A-II particles contain ApoA-II as the sole apolipoprotein constituent; however, small subsets of LP-A-II particles may also contain ApoD and other minor apolipoproteins. The lipid/protein ratio of LP-A-II is higher than those of LP-A-I and LP-A-I:A-II. In homozygous ApoA-I and ApoA-I/ApoC-III deficiencies, LP-A-II particles are the only ApoA-containing high density lipoprotein with levels found to be within the same range (7-13 mg/dl) as those of normolipidemic subjects. However, in contrast to normal LP-A-II, their lipid composition is characterized by higher percentages of triglycerides and cholesterol esters and a lower percentage of phospholipids and their apolipoprotein composition by the presence of ApoC-peptides and ApoE in addition to ApoA-II and ApoD. These results show that LP-A-II particles are a minor HDL family and suggest that, in the absence of ApoA-I-containing lipoproteins, they become an efficient acceptor/donor of ApoC-peptides and ApoE required for a normal metabolism of triglyceride-rich lipoproteins. Their other possible functional roles in lipid transport remain to be established in future experiments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606170     DOI: 10.1016/0005-2760(92)90223-i

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.

Authors:  M A Clay; D A Cehic; D H Pyle; K A Rye; P J Barter
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

2.  ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis.

Authors:  Yaoyong Wang; Jinko Sawashita; Jinze Qian; Beiru Zhang; Xiaoying Fu; Geng Tian; Lei Chen; Masayuki Mori; Keiichi Higuchi
Journal:  J Lipid Res       Date:  2011-05-26       Impact factor: 5.922

3.  Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles.

Authors:  S Lund-Katz; Y M Murley; E Yon; K L Gillotte; W S Davidson
Journal:  Lipids       Date:  1996-11       Impact factor: 1.880

4.  Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles.

Authors:  Malgorzata Wróblewska; Barbara Kortas-Stempak; Andrzej Szutowicz; Tadeusz Badzio
Journal:  J Lipid Res       Date:  2008-12-09       Impact factor: 5.922

5.  Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.

Authors:  James P Corsetti; Stephan J L Bakker; Charles E Sparks; Robin P F Dullaart
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

6.  HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients.

Authors:  Iva Klobučar; Vesna Degoricija; Ines Potočnjak; Matias Trbušić; Gudrun Pregartner; Andrea Berghold; Eva Fritz-Petrin; Hansjörg Habisch; Tobias Madl; Saša Frank
Journal:  Biomedicines       Date:  2022-07-11

7.  Isolation of HDL by sequential flotation ultracentrifugation followed by size exclusion chromatography reveals size-based enrichment of HDL-associated proteins.

Authors:  Jack Jingyuan Zheng; Joanne K Agus; Brian V Hong; Xinyu Tang; Christopher H Rhodes; Hannah E Houts; Chenghao Zhu; Jea Woo Kang; Maurice Wong; Yixuan Xie; Carlito B Lebrilla; Emily Mallick; Kenneth W Witwer; Angela M Zivkovic
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.